European expert guidance on management of sleep onset insomnia and melatonin use in typically developing children

Area of Science:

• Pediatric Sleep Medicine
• Chronobiology
• Child Neurology

Background:

• Sleep problems are common in children and adolescents, leading to frequent pediatrician visits.
• Cognitive-behavioral therapy is effective for short-term sleep onset insomnia management.
• Global guidelines for pharmaceutical interventions in pediatric sleep onset insomnia are lacking.

Purpose of the Study:

• To develop practical recommendations for pediatricians managing sleep onset insomnia in typically developing children.
• To provide a stepwise approach for pediatric sleep onset insomnia treatment.
• To address the need for evidence-based guidelines on melatonin use in children.

Main Methods:

• An expert panel of pediatric sleep specialists and chronobiologists convened in October 2023.
• Recommendations were developed based on current evidence and clinical expertise.
• A stepwise management approach was outlined, prioritizing non-pharmacological interventions.

Main Results:

• The initial step involves implementing sleep hygiene and adaptive bedtime routines.
• Behavioral therapies should follow if sleep hygiene measures are insufficient.
• Low-dose melatonin, given 30-60 minutes before bedtime, may be considered for children over two years old if other methods fail.

Conclusions:

• Low-dose melatonin is a viable option for managing sleep onset insomnia in children.
• Melatonin should be used cautiously and monitored by pediatricians for efficacy and side effects.
• This approach supports evidence-based, stepwise management of pediatric sleep onset insomnia.